4//SEC Filing
Lavino Francesco Maria 4
Accession 0001104659-19-047352
CIK 0001641640other
Filed
Aug 25, 8:00 PM ET
Accepted
Aug 26, 9:49 PM ET
Size
5.1 KB
Accession
0001104659-19-047352
Insider Transaction Report
Form 4
Lavino Francesco Maria
Chief Commercial Officer
Transactions
- Purchase
Ordinary Shares
2019-08-22$2.04/sh+4,800$9,780→ 15,972 total
Footnotes (1)
- [F1]The reporting person's purchase of ordinary shares of Nabriva Therapeutics plc (the "Issuer") reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 4,800 shares, with the reporting person's sale of 3,797 ordinary shares at a price of $2.08 per share on August 21, 2019. The reporting person has agreed to pay to the Issuer $204, representing the full amount of the profit realized in connection with the short-swing transaction.
Documents
Issuer
Nabriva Therapeutics plc
CIK 0001641640
Entity typeother
Related Parties
1- filerCIK 0001711517
Filing Metadata
- Form type
- 4
- Filed
- Aug 25, 8:00 PM ET
- Accepted
- Aug 26, 9:49 PM ET
- Size
- 5.1 KB